Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism:

First Page		Document Content
Date: 2014-11-20 01:49:16 Drugs Targeted therapy Epidermal growth factor receptor Head and neck cancer Nimotuzumab Zalutumumab Medicine Biology Oncology		Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism: Add to Reading List Source URL: www.cprit.state.tx.us Download Document from Source Website File Size: 45,14 KB Share Document on Facebook

	Q&A GENMAB 8TH OF MAY 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 8TH OF MAY 2014 DocID: 16V15 - View Document
	Advancing the Frontier of Antibody Therapeutics Kirsten Drejer, PhD Chief Executive Officer DocID: 15xRI - View Document
	Clinical Cancer Research Cancer Therapy: Clinical DocID: VWRp - View Document
	Award ID: RP110252 Project Title: Deciphering the mechanisms of EGFR-regulated Warburg effect during tumorigenesis Award Mechanism: DocID: J40s - View Document
	Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism: DocID: IU4U - View Document